Interlaboratory Reliability of 3D Gait Analysis

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine the interlaboratory reliability of 3D gait analysis performed on healthy subjects on an instrumented treadmill in three different laboratories. This will allow us to evaluate whether the pooling of control data is feasible in future studies. This will support our ambitions to enter into future collaborations to conduct studies with larger samples. Moreover, this way we will know if we can share patient data in the future so that patients can be specifically referred to a lab with expertise on a particular evaluation, e.g. the lab in Maastricht has expertise on perturbations, UZ Gent has expertise on full-body measurements and UHasselt has expertise on balance. During this study approximately 30 healthy subjects will be recruited (10 from each center) from the staff and students at each center. These subjects are own staff and students of the 3 centers. Each subject will undergo a 3D gait analysis at each center (at UZGent, UHasselt and UMaastricht). Therefore, each subject will be evaluated 3 times. The time between each evaluations will be a maximum of one week. The evaluations will be performed as per standard procedure in each lab. However, a standardized model (HBM2 lower limb), an agreed walking velocity (0.9 m/s, 1.0 m/s, 1.1 m/s) and an agreed duration per recording (3 min) will be used. The same software will be used to process the collected data. 3D kinematics and kinetic time-series data of the lower limbs will be extracted as outcome data. Absolute reliability indices will be calculated in the following way: First, the standard deviation (SD) of time-series data across different gait cycles will be calculated per participant per center. The SD values across different centers per participant will then be averaged. Finally, the SD values across different participants will form the inter-laboratory reliability indices. In addition, we will use statistical parametric mapping (Anova repeated measures) to compare the full time-series data of each outcome parameter.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05530213
Study type	Interventional
Source	University Ghent
Contact	Lynn Bar-On, PhD
Phone	+32 9 332 26 32
Email	lynn.baron@ugent.be
Status	Recruiting
Phase	N/A
Start date	October 1, 2022
Completion date	September 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04867148` - The Prediction and Prevention of Disease by Using Big Data in Motion Analysis	N/A
Completed	`NCT05538221` - Reliability of a Gait Analysis System
Recruiting	`NCT05277181` - Wearable Technology as an Objective Tool for Measuring Running Gait
Recruiting	`NCT05989113` - Psychometric Qualities IPAQ-SF
Not yet recruiting	`NCT05305755` - Reliability of a Gait Analysis System
Not yet recruiting	`NCT06264999` - Robotic Assisted Knee Arthroplasty - Retain the Anterior Cruciate Ligament or Not	N/A
Completed	`NCT03898544` - Gait Kinematics After Primary Total Knee Arthroplasty (TKA) Versus Revision TKA
Completed	`NCT05957783` - Changes in Upper Limb Kinematics in Children With Cerebral Palsy After Lower Limb Surgery
Recruiting	`NCT05751408` - Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis
Completed	`NCT04788719` - Pre and Postoperative Gait Analysis of Randomized Patient to 2 Different Cement Fixation Methods	N/A
Completed	`NCT04791605` - Gait Pattern Between a Cemented and Non-cemented Femur Stem	N/A
Withdrawn	`NCT03858556` - Effect of Chuna Manipulation Therapy on Gait in Patients With Lumbar Disc Herniation
Completed	`NCT04529642` - Is the 6-Minute Walking Test Combined With an IMU Useful in Stroke Rehabilitation Assessment?
Recruiting	`NCT05452655` - Intensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's Disease	N/A
Not yet recruiting	`NCT05855577` - Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients	Phase 4
Recruiting	`NCT06253624` - Gait Pattern Analysis After All Arthroscopic ATFL Repair Surgery	N/A
Completed	`NCT04230733` - Pelvis Displacement and Gait Indicators in Patient With Lumbar Disc Herniation
Recruiting	`NCT06304077` - Restorative Environments for Gait Therapy With VR	N/A
Completed	`NCT01620021` - Feasibility of Wearable Sensors to Determine Gait Parameters	N/A
Completed	`NCT04434313` - Treatment of Hemiparetic Gait Impairments Using Telehealth With the Moterum iStride Solution™	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.